Antiproliferative and Proapoptotic Effects of Phenanthrene Derivatives Isolated from Bletilla striata on A549 Lung Cancer Cells
Abstract
:1. Introduction
2. Results
2.1. Structure Elucidation
2.2. Cytotoxicity of the Isolates against A549 and BEAS-2B Cells
2.3. Compound 1 Inhibited Cell Proliferation and Induced Cell Cycle Arrest at G2/M Phase of A549 Cells
2.4. Compound 1 Inhibited Migration of A549 Cells
2.5. Compound 1 Induced Apoptosis of A549 Cells
2.6. Compound 1 Inhibited Proliferation of A549 Cells via Suppressing the Akt and MEK/ERK Signaling Pathways
2.7. Compound 1 Induced Apoptosis of A549 Cells by Regulating Bcl-2/Bax Signaling Pathway
3. Discussion
4. Materials and Methods
4.1. General Procedures
4.2. Plant Material
4.3. Extraction and Isolation
4.4. Cytotoxic Activity Assay
4.5. EdU Proliferation Experiment
4.6. Cell Cycle Analysis
4.7. Wound Healing Assay
4.8. Transwell Migration Assay
4.9. Apoptosis by Flow Cytometry Assay
4.10. Western Blot Analysis
4.11. Statistical Analysis
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Sample Availability
References
- Jones, G.S.; Baldwin, D.R. Recent advances in the management of lung cancer. Clin. Med. 2018, 18, s41–s46. [Google Scholar] [CrossRef] [PubMed]
- Siegel, R.L.; Miller, K.D.; Jemal, A. Cancer statistics, 2018. CA Cancer J. Clin. 2018, 68, 7–30. [Google Scholar] [CrossRef] [PubMed]
- García-Campelo, R.; Bernabé, R.; Cobo, M.; Corral, J.; Coves, J.; Dómine, M.; Nadal, E.; Rodriguez-Abreu, D.; Viñolas, N.; Massuti, B. SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2015. Clin. Transl. Oncol. 2015, 17, 1020–1029. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Jonna, S.; Subramaniam, D.S. Molecular diagnostics and targeted therapies in non-small cell lung cancer (NSCLC): An update. Discov. Med. 2019, 27, 167–170. [Google Scholar] [PubMed]
- Zhang, C.; Leighl, N.B.; Wu, Y.L.; Zhong, W.Z. Emerging therapies for non-small cell lung cancer. J. Hematol. Oncol. 2019, 12, 47. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zhang, X.W.; Liu, W.; Jiang, H.L.; Mao, B. Chinese herbal medicine for advanced non-small-cell lung cancer: A systematic review and meta-analysis. Am. J. Chin. Med. 2018, 46, 923–952. [Google Scholar] [CrossRef]
- Jiang, Z.B.; Huang, J.M.; Xie, Y.J.; Zhang, Y.Z.; Chang, C.; Lai, H.L.; Wang, W.; Yao, X.J.; Fan, X.X.; Wu, Q.B.; et al. Evodiamine suppresses non-small cell lung cancer by elevating CD8+ T cells and downregulating the MUC1-C/PD-L1 axis. J. Exp. Clin. Cancer Res. 2020, 39, 249. [Google Scholar] [CrossRef]
- He, X.; Wang, X.; Fang, J.; Zhao, Z.; Huang, L.; Guo, H.; Zheng, X. Bletilla striata: Medicinal uses, phytochemistry and pharmacological activities. J. Ethnopharmacol. 2017, 195, 20–38. [Google Scholar] [CrossRef]
- Jiang, F.; Li, M.; Wang, H.; Ding, B.; Zhang, C.; Ding, Z.; Yu, X.; Lv, G. Coelonin, anti-inflammation active component of Bletilla striata and its potential mechanism. Int. J. Mol. Sci. 2019, 20, 4422. [Google Scholar] [CrossRef] [Green Version]
- Ji, X.; Yin, M.; Nie, H.; Liu, Y. A review of isolation, chemical properties, and bioactivities of polysaccharides from Bletilla striata. Biomed. Res. Int. 2020, 2020, 5391379. [Google Scholar] [CrossRef]
- Woo, K.W.; Park, J.E.; Choi, S.U.; Kim, K.H.; Lee, K.R. Phytochemical constituents of Bletilla striata and their cytotoxic activity. Nat. Prod. Sci. 2014, 20, 91–94. [Google Scholar]
- Sun, A.; Liu, J.; Pang, S.; Lin, J.; Xu, R. Two novel phenanthraquinones with anti-cancer activity isolated from Bletilla striata. Bioorg. Med. Chem. Lett. 2016, 26, 2375–2379. [Google Scholar] [CrossRef] [PubMed]
- Sun, M.H.; Ma, X.J.; Shao, S.Y.; Han, S.W.; Jiang, J.W.; Zhang, J.J.; Li, S. Phenanthrene, 9,10-dihydrophenanthrene and bibenzyl enantiomers from Bletilla striata with their antineuroinflammatory and cytotoxic activities. Phytochemistry 2021, 182, 112609. [Google Scholar] [CrossRef]
- Zhu, H.; Dai, O.; Zhou, F.; Yang, L.; Liu, F.; Liu, Y.; He, Y.L.; Bu, L.; Guo, L.; Peng, C.; et al. Discovery of bletillain, an unusual benzyl polymer with significant autophagy-inducing effects in A549 lung cancer cells through the Akt/GSK-3β/β-catenin signaling pathway. Bioorg. Chem. 2021, 117, 105449. [Google Scholar] [CrossRef] [PubMed]
- Bai, L.; Kato, T.; Inoue, K.; Yamaki, M.; Takagi, S. Blestrianol A, B and C, biphenanthrenes from Bletilla striata. Phytochemistry 1991, 30, 2733–2735. [Google Scholar] [CrossRef]
- Matsuda, H.; Morikawa, T.; Xie, H.; Yoshikawa, M. Antiallergic phenanthrenes and stilbenes from the tubers of Gymnadenia conopsea. Planta Med. 2004, 70, 847–855. [Google Scholar] [CrossRef]
- Lin, C.W.; Hwang, T.L.; Chen, F.A.; Huang, C.H.; Hung, H.Y.; Wu, T.S. Chemical constituents of the rhizomes of Bletilla formosana and their potential anti-inflammatory activity. J. Nat. Prod. 2016, 79, 1911–1921. [Google Scholar] [CrossRef]
- Yamaki, M.; Bai, L.; Inoue, K.; Takagi, S. Biphenanthrenes from Bletilla striata. Phytochemistry 1989, 28, 3503–3505. [Google Scholar] [CrossRef]
- Tuchinda, P.; Udchachon, J.; Khumtaveeporn, K.; Taylor, W.C.; Engelhardt, L.M.; White, A.H. Phenanthrenes of Eulophia nuda. Phytochemistry 1988, 27, 3267–3271. [Google Scholar] [CrossRef]
- Lin, Y.L.; Chen, W.P.; Macabalang, A.D. Dihydrophenanthrenes from Bletilla formosana. Chem. Pharm. Bull. 2005, 53, 1111–1113. [Google Scholar] [CrossRef] [Green Version]
- Tagaki, S.; Yamaki, M.; Inoue, K. Antimicrobial agents from Bletilla striata. Phytochemistry 1983, 22, 1011–1015. [Google Scholar] [CrossRef]
- Shiao, Y.J.; Chen, W.P.; Lin, Y.L. New polyphenols and triterpene from the pseudobulbs of Pleione formosana. J. Chin. Chem. Soc. 2009, 56, 828–833. [Google Scholar] [CrossRef]
- Yamaki, M.; Bai, L.; Inoue, K.; Takagi, S. Benzylphenanthrenes from Bletilla striata. Phytochemistry 1990, 29, 2285–2287. [Google Scholar] [CrossRef]
- Bai, L.; Kato, T.; Inoue, K.; Yamaki, M.; Takagi, S. Stilbenoids from Bletilla striata. Phytochemistry 1993, 33, 1481–1483. [Google Scholar] [CrossRef]
- Majumder, P.L.; Banerjee, S. Two stilbenoids from the orchid Eria flava. Phytochemistry 1990, 29, 3052–3055. [Google Scholar] [CrossRef]
- Collins, L.G.; Haines, C.; Perkel, R.; Enck, R.E. Lung cancer: Diagnosis and management. Am. Fam. Physician. 2007, 75, 56–63. [Google Scholar]
- Hoy, H.; Lynch, T.; Beck, M. Surgical treatment of lung cancer. Crit. Care Nurs. Clin. N. Am. 2019, 31, 303–313. [Google Scholar] [CrossRef]
- Hann, C.L.; Rudin, C.M. Management of small-cell lung cancer: Incremental changes but hope for the future. Oncology (Williston Park) 2008, 22, 1486–1492. [Google Scholar]
- Tang, M.; Wang, S.; Zhao, B.; Wang, W.; Zhu, Y.; Hu, L.; Zhang, X.; Xiong, S. Traditional Chinese medicine prolongs progression-free survival and enhances therapeutic effects in epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) treated non-small-cell lung cancer (NSCLC) patients harboring EGFR mutations. Med. Sci. Monit. 2019, 25, 8430–8437. [Google Scholar] [CrossRef]
- Wan, L.Q.; Tan, Y.; Jiang, M.; Hua, Q. The prognostic impact of traditional Chinese medicine monomers on tumor-associated macrophages in non-small cell lung cancer. Chin. J. Nat. Med. 2019, 17, 729–737. [Google Scholar] [CrossRef]
- Sui, J.; Tang, C.; Ke, C.Q.; Ye, Y. Dimeric 9,10-dihydrophenanthrene derivatives from Bletilla striata and their atropisomeric nature. Fitoterapia 2021, 152, 104919. [Google Scholar] [CrossRef] [PubMed]
- Jia, X.B.; Zhang, Q.; Xu, L.; Yao, W.J.; Wei, L. Lotus leaf flavonoids induce apoptosis of human lung cancer A549 cells through the ROS/p38 MAPK pathway. Biol. Res. 2021, 54, 7. [Google Scholar] [CrossRef] [PubMed]
- Hartwell, L.H.; Kastan, M.B. Cell cycle control and cancer. Science 1994, 266, 1821–1828. [Google Scholar] [CrossRef] [PubMed]
- Kastan, M.B.; Bartek, J. Cell-cycle checkpoints and cancer. Nature 2004, 432, 316–323. [Google Scholar] [CrossRef] [PubMed]
- Thakuri, P.S.; Gupta, M.; Singh, S.; Joshi, R.; Glasgow, E.; Lekan, A.; Agarwal, S.; Luker, G.D.; Tavana, H. Phytochemicals inhibit migration of triple negative breast cancer cells by targeting kinase signaling. BMC Cancer 2020, 20, 4. [Google Scholar] [CrossRef] [Green Version]
- Lin, J.E.; Li, P.; Pitari, G.M.; Schulz, S.; Waldman, S.A. Guanylyl cyclase C in colorectal cancer: Susceptibility gene and potential therapeutic target. Future Oncol. 2009, 5, 509–522. [Google Scholar] [CrossRef] [Green Version]
- Kim, E.K.; Choi, E.J. Pathological roles of MAPK signaling pathways in human diseases. Biochim. Biophys. Acta 2020, 1802, 396–405. [Google Scholar] [CrossRef] [Green Version]
- Meng, G.; Chai, K.; Li, X.; Zhu, Y.; Huang, W. Luteolin exerts pro-apoptotic effect and anti-migration effects on A549 lung adenocarcinoma cells through the activation of MEK/ERK signaling pathway. Chem. Biol. Interact. 2016, 257, 26–34. [Google Scholar] [CrossRef]
- Ren, M.; Xu, W.; Xu, T. Salidroside represses proliferation, migration and invasion of human lung cancer cells through AKT and MEK/ERK signal pathway. Artif. Cells. Nanomed. Biotechnol. 2019, 47, 1014–1021. [Google Scholar] [CrossRef] [Green Version]
- Yue, S.J.; Zhang, P.X.; Zhu, Y.; Li, N.G.; Chen, Y.Y.; Li, J.J.; Zhang, S.; Jin, R.Y.; Yan, H.; Shi, X.Q.; et al. A ferulic acid derivative FXS-3 inhibits proliferation and metastasis of human lung cancer A549 cells via positive JNK signaling pathway and negative ERK/p38, AKT/mTOR and MEK/ERK signaling pathways. Molecules 2019, 24, 2165. [Google Scholar] [CrossRef] [Green Version]
- Kasibhatla, S.; Tseng, B. Why target apoptosis in cancer treatment? Mol. Cancer Ther. 2003, 2, 573–580. [Google Scholar] [PubMed]
- Kaushal, G.P.; Liu, L.; Kaushal, V.; Hong, X.; Melnyk, O.; Seth, R.; Safirstein, R.; Shah, S.V. Regulation of caspase-3 and -9 activation in oxidant stress to RTE by forkhead transcription factors, Bcl-2 proteins, and MAP kinases. Am. J. Physiol. Renal Physiol. 2004, 287, F1258–F1268. [Google Scholar] [CrossRef] [PubMed]
- Wu, Y.L.; Xia, L.J.; Li, J.Y.; Zhang, F.C. CecropinXJ inhibits the proliferation of human gastric cancer BGC823 cells and induces cell death in vitro and in vivo. Int. J. Oncol. 2015, 46, 2181–2193. [Google Scholar] [CrossRef] [PubMed] [Green Version]
No. | 1 | 2 | ||
---|---|---|---|---|
1H | 13C | 1H | 13C | |
1 | 114.6 | 112.0 | ||
2 | 155.3 | 155.9 | ||
3 | 6.61 (s) | 99.0 | 6.65 s | 99.1 |
4 | 158.2 | 158.5 | ||
4a | 116.9 | 117.1 | ||
4b | 126.1 | 125.9 | ||
5 | 8.09 d (8.4) | 130.1 | 8.09 d (8.4) | 130.1 |
6 | 6.69 dd (8.4, 2.4) | 113.3 | 6.69 dd (8.4, 2.4) | 114.1 |
7 | 156.1 | 156.5 | ||
8 | 6.66 d (2.4) | 114.7 | 6.69 d (2.4) | 114.7 |
8a | 140.2 | 140.3 | ||
9 | 2.47–2.53 m, 2.56–2.61 m | 30.6 | 2.55–2.58 m, 2.59–2.64 m | 30.3 |
10 | 2.27–2.34 m, 2.35–2.41 m | 27.9 | 2.44–2.50 m, 2.51–2.55 m | 28.3 |
10a | 140.7 | 141.6 | ||
1′ | 121.5 | 6.69 s | 114.7 | |
2′ | 154.3 | 156.1 | ||
3′ | 6.80 d (8.4) | 113.4 | 116.6 | |
4′ | 8.10 d (8.4) | 129.5 | 155.9 | |
4′a | 126.2 | 126.0 | ||
4′b | 116.8 | 120.9 | ||
5′ | 158.7 | 8.10 d (8.4) | 129.4 | |
6′ | 6.47 d (2.4) | 98.9 | 6.71 d (8.4) | 113.4 |
7′ | 157.3 | 153.2 | ||
8′ | 6.35 d (2.4) | 107.9 | 121.7 | |
8′a | 141.5 | 140.0 | ||
9′ | 2.47–2.53 m, 2.56–2.61 m | 31.2 | 2.59–2.64 m, 2.66–2.70 m | 27.1 |
10′ | 2.27–2.34 m 2.35–2.41 m | 27.2 | 2.59–2.64 m, 2.66–2.70 m | 30.3 |
10′a | 139.7 | 140.0 | ||
1″ | 132.9 | |||
2″ | 7.08 d (9.0) | 130.0 | ||
3″ | 6.71 d (9.0) | 115.8 | ||
4″ | 156.1 | |||
5″ | 6.71 d (9.0) | 115.8 | ||
6″ | 7.08 d (9.0) | 130.0 | ||
7″ | 4.03 d (15.6), 4.11 d (15.6) | 31.5 | ||
OMe-4 | 3.89 s | 55.7 | 3.90 s | 55.6 |
OMe-8 | ||||
OMe-4′ | 3.26 s | 59.8 | ||
OMe-5′ | 3.87 s | 55.7 | ||
OH-2 | 7.43 s | |||
OH-7 | 8.10 s | |||
OH-2′ | 7.34 s | |||
OH-7′ | 8.24 s |
Compounds | IC50 (μM) a | Compounds | IC50 (μM) a |
---|---|---|---|
1 | 6.86 ± 0.71 | 10 | 16.29 ± 2.22 |
2 | 8.75 ± 0.61 | 11 | - b |
3 | 10.50 ± 2.55 | 12 | 33.30 ± 0.49 |
4 | 9.91 ± 0.68 | 13 | 9.52 ± 0.47 |
5 | >100 | 14 | 12.03 ± 0.79 |
6 | 9.45 ± 0.52 | 15 | - b |
7 | 3.43 ± 0.21 | 16 | 63.80 ± 4.67 |
8 | 8.62 ± 0.64 | 17 | 32.61 ± 2.33 |
9 | 51.47 ± 1.87 | Paclitaxel | (1.52 ± 0.02) × 10−2 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Zhou, F.; Feng, R.; Dai, O.; Yang, L.; Liu, Y.; Tian, Y.-C.; Peng, C.; Xiong, L. Antiproliferative and Proapoptotic Effects of Phenanthrene Derivatives Isolated from Bletilla striata on A549 Lung Cancer Cells. Molecules 2022, 27, 3519. https://doi.org/10.3390/molecules27113519
Zhou F, Feng R, Dai O, Yang L, Liu Y, Tian Y-C, Peng C, Xiong L. Antiproliferative and Proapoptotic Effects of Phenanthrene Derivatives Isolated from Bletilla striata on A549 Lung Cancer Cells. Molecules. 2022; 27(11):3519. https://doi.org/10.3390/molecules27113519
Chicago/Turabian StyleZhou, Fei, Rui Feng, Ou Dai, Lian Yang, Yu Liu, Yun-Cai Tian, Cheng Peng, and Liang Xiong. 2022. "Antiproliferative and Proapoptotic Effects of Phenanthrene Derivatives Isolated from Bletilla striata on A549 Lung Cancer Cells" Molecules 27, no. 11: 3519. https://doi.org/10.3390/molecules27113519